Indutrade came into today with the share price roughly flat over the past month and slightly weaker over the past week, hardly the setup you might associate with a strong headline. Q3 2026 told a different story. Earnings per share reached 2.21 SEK and net income landed at 804 million SEK, while the earnings call highlighted a clear profit upswing with EBITA growth and a higher EBITA margin.
The stock closed at SEK247.6. The real action, however, was in the P&L, where profitability rather than top line volume did the heavy lifting. That gap between a muted price move and firmer earnings power is what matters for holders now.
Appreciate Indutrade’s stronger EBITA margin, but uneasy that the share price has barely reacted. Use the 193 high quality undervalued stocks as a benchmark to see how other profitable, high quality stocks are being priced by the market.
The bullish pitch on Indutrade hinges on order books and acquisitions feeding through to richer earnings rather than just higher sales.
"The main thing that has to go right is that Indutrade converts its record order books and margin accretive acquisitions into sustained earnings development while keeping SG&A from rising in line with sales."
Q3 gives hard evidence in that direction. Organic sales rose 5%, EBITA increased 19% and the EBITA margin stepped up to 15.3%, while book to bill stayed just above 1 and backlog climbed 11%. With 13 year to date deals around 18% EBITA margins and SG&A still under control, the profit mix is already shifting the way the thesis assumes.
One Narrative disagrees with today's price. → See where this Narrative says Indutrade should trade.
Bearish investors question whether Indutrade can turn fuller order books into enough physical shipments to keep earnings momentum intact.
"Although Indutrade reported stronger order intake and an improving book to bill ratio in 2026, the flat organic net sales and 13.3% EBITA margin in Q1 2026 show that low organic volume growth can still absorb pricing gains."
Q3 shows that concern only partly addressed. Organic sales grew 5% and EBITA rose faster than revenue, yet book to bill only just cleared 1 and the backlog skewed further to long lead projects. Profit delivery looks healthier, though the specific fear of subdued volumes has not been fully disproved by one stronger quarter.
Indutrade just showed how a stronger margin profile can sit beside a muted share price. The real opportunity is spotting companies that could be undervalued before the market closes that gap.
Those are three of them. See all 193 potentially undervalued companies →
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com